These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9479035)

  • 21. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.
    Breese GR; Napier TC; Mueller RA
    J Pharmacol Exp Ther; 1985 Aug; 234(2):447-55. PubMed ID: 3926987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Priming of rotational behavior by a dopamine receptor agonist in Hemiparkinsonian rats: movement-dependent induction.
    Simola N; Di Chiara G; Daniels WM; Schallert T; Morelli M
    Neuroscience; 2009 Feb; 158(4):1625-31. PubMed ID: 19063947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sensitization to apomorphine-induced rotational behavior in 6-OHDA-lesioned rats: effects of NMDA antagonists on drug response.
    Gancher S; Mayer A
    Brain Res; 1995 Jun; 682(1-2):63-8. PubMed ID: 7552328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Use of Perinatal 6-Hydroxydopamine to Produce a Rodent Model of Lesch-Nyhan Disease.
    Knapp DJ; Breese GR
    Curr Top Behav Neurosci; 2016; 29():265-277. PubMed ID: 27029809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopamine, serotonin and tachykinin in self-injurious behavior.
    Sivam SP
    Life Sci; 1996 May; 58(26):2367-75. PubMed ID: 8691981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NMDA glutamate receptor stimulation is required for the expression of D2 dopamine mediated responses in apomorphine primed 6-hydroxydopamine lesioned rats.
    Pollack AE; Haisley EC
    Brain Res; 2001 Apr; 897(1-2):213-6. PubMed ID: 11282380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopamine deficiency in self-injurious behavior.
    Breese GR; Criswell HE; Duncan GE; Mueller RA
    Psychopharmacol Bull; 1989; 25(3):353-7. PubMed ID: 2697009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Behavioral and neurochemical dynamics of neurotoxic meso-striatal dopamine lesions.
    Schwarting RK; Huston JP
    Neurotoxicology; 1997; 18(3):689-708. PubMed ID: 9339817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for involvement of brain dopamine and other mechanisms in the behavioral action of the N-methyl-D-aspartic acid antagonist MK-801 in control and 6-hydroxydopamine-lesioned rats.
    Criswell HE; Johnson KB; Mueller RA; Breese GR
    J Pharmacol Exp Ther; 1993 May; 265(2):1001-10. PubMed ID: 8098756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopamine re-uptake inhibitor GBR-12909 induction of aberrant behaviors in animal models of dopamine dysfunction.
    Loupe PS; Bredemeier JD; Schroeder SR; Tessel RE
    Int J Dev Neurosci; 2002; 20(3-5):323-33. PubMed ID: 12175869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FR discrimination training reverses 6-hydroxydopamine-induced striatal dopamine depletion in a rat model of Lesch-Nyhan syndrome.
    Stodgell CJ; Schroeder SR; Tessel RE
    Brain Res; 1996 Mar; 713(1-2):246-52. PubMed ID: 8724997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ginkgo biloba affords dose-dependent protection against 6-hydroxydopamine-induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences.
    Ahmad M; Saleem S; Ahmad AS; Yousuf S; Ansari MA; Khan MB; Ishrat T; Chaturvedi RK; Agrawal AK; Islam F
    J Neurochem; 2005 Apr; 93(1):94-104. PubMed ID: 15773909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intrastriatal serotonin 5-HT2 receptors mediate dopamine D1-induced hyperlocomotion in 6-hydroxydopamine-lesioned rats.
    Bishop C; Kamdar DP; Walker PD
    Synapse; 2003 Nov; 50(2):164-70. PubMed ID: 12923819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of purine-dopamine interactions in 6-hydroxydopamine-lesioned rats: evidence for pre- and postsynaptic influences by adenosine.
    Criswell H; Mueller RA; Breese GR
    J Pharmacol Exp Ther; 1988 Feb; 244(2):493-500. PubMed ID: 3126293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monoaminergic PET imaging and histopathological correlation in unilateral and bilateral 6-hydroxydopamine lesioned rat models of Parkinson's disease: a longitudinal in-vivo study.
    Molinet-Dronda F; Gago B; Quiroga-Varela A; Juri C; Collantes M; Delgado M; Prieto E; Ecay M; Iglesias E; Marín C; Peñuelas I; Obeso JA
    Neurobiol Dis; 2015 May; 77():165-72. PubMed ID: 25681534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 6-OHDA-induced lesion of the nigrostriatal dopaminergic neurons potentiates the inhibitory effect of 7-OHDPAT, a selective D3 agonist, on acetylcholine release during striatal microdialysis in conscious rats.
    Sato K; Ueda H; Okumura F; Misu Y
    Brain Res; 1994 Aug; 655(1-2):233-6. PubMed ID: 7812777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pemoline alters dopamine modulation of synaptic responses of neostriatal neurons in vitro.
    Cromwell HC; King BH; Levine MS
    Dev Neurosci; 1997; 19(6):497-504. PubMed ID: 9445087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Upregulation of striatal adenosine A2A receptor mRNA in 6-hydroxydopamine-lesioned rats intermittently treated with L-DOPA.
    Tomiyama M; Kimura T; Maeda T; Tanaka H; Kannari K; Baba M
    Synapse; 2004 Jun; 52(3):218-22. PubMed ID: 15065221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Place conditioning to apomorphine in rat models of Parkinson's disease: differences by dose and side-effect expression.
    Campbell JC; Jeyamohan SB; De La Cruz P; Chen N; Shin D; Pilitsis JG
    Behav Brain Res; 2014 Dec; 275():114-9. PubMed ID: 25205367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Behavioral and cross sensitization after repeated exposure to modafinil and apomorphine in rats.
    Chang ST; Tung CS; Lin YL; Chuang CH; Lee AR; Liu YP
    Chin J Physiol; 2010 Oct; 53(5):318-27. PubMed ID: 21793343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.